The influence of interleukin gene polymorphism on expression of interleukin-1β and tumor necrosis factor-α in periodontal tissue and gingival crevicular fluid

Journal of Periodontology

Volumn 70, Issue 6, 1999, Pages 567-573

  Engebretson, Steven P ^a,d   Lamster, Ira B ^a   Herrera Abreu, Miriam ^a   Celenti, Romanita S ^a   Timms, Janine M ^b   Chaudhary, Adeel G A ^b   Di Giovine, Francesco S ^b   Kornman, Kenneth S ^c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c Medical Science Systems   (United States)

^d New York Presbyterian Hospital   (United States)

Author keywords

Cytokines; Gingival crevicular fluid; Interleukin 1; Periodontitis therapy; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BIOSYNTHESIS; CHEMISTRY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GINGIVA; GINGIVITIS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PERIODONTITIS; POLYMERASE CHAIN REACTION; PREVENTIVE DENTISTRY;

ADULT; ANALYSIS OF VARIANCE; DENTAL SCALING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GINGIVA; GINGIVAL CREVICULAR FLUID; HUMANS; INTERLEUKIN-1; MALE; MIDDLE AGED; PERIODONTAL POCKET; PERIODONTITIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033146144     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1999.70.6.567     Document Type: Article

References (21)

1. Hirschfeld L, Wasserman B. A long-term survey of tooth loss in 600 treated periodontal patients. J Periodontol 1978;49:225-237.
2. Lindhe J, Nyman S. Long-term maintenance of patients treated for advanced periodontal disease. J Clin Periodontol 1984;11:504-514.
3. Haffajee AD, Socransky SS. Microbial etiological agents of destructive periodontal diseases. Periodontol 2000 1994;5:78-111.
4. Kinane DF, Winstanley FP, Adonogianaki E, Moughal NA. Bioassay of interleukin 1 (IL-1) in human gingival crevicular fluid during experimental gingivitis. Arch Oral Biol 1992;37:153-156.
5. Stashenko R, Fujiyoshi R, Obernesser MS, Prostak L, Haffajee AD, Socransky SS. Levels of interleukin-1ß in tissue from sites of active periodontal disease. J Clin Periodontol 1991;18:548-554.
6. Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodont Res 1993;28:500-510.
7. Duff GW. Molecular genetics of cytokines: Cytokines in chronic inflammatory disease. In: Thompson A, ed. The Cytokine Handbook, 2nd ed. London: Academic Press Ltd; 1994:21-30.
8. Mansfield JC, Holden H, Tarlow JK. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterol 1994;106:637-642.
9. Cork M, di Giovine F, Crane S, Mee J, Duff G. Novel genetic association of an II-1-beta gene variation at +3953, susceptibility to psoriasis and II-1-beta protein-production. J Invest Dermatol 1995;105:453(abstr. 32).
10. Blakemore A, Tarlow J, Cork M, Gordon C, Emery P, Duff G. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 1994;37:1380-1385.
11. Kornman KS, Crane A, Wang H-Y, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997;24:72-77.
12. Nicklin M, Weith A, Duff G. A physical map of the region encompassing the human interleukin-1 alpha, beta and the interleukin-1 receptor antagonist genes. Genomics 1994;19:382-384.
13. Lamster IB, Oshrain RL, Florello LA, Celenti RS, Gordon JM. A comparison of 4 methods of data presentation for lysosomal enzyme activity in gingival crevicular fluid. J Clin Periodontol 1988;15:347-352.
14. Tagariello G, di Giovine F. Interleukin-1 in hemophilic arthritis. Thromb Haemost 1996;75:979-980.
15. Ahn S, Costa J, Emanuel J. Picogreen quantitation of DNA - Effective evaluation of samples pre-PCR or post-PCR. Nucleic Acid Res 1996;24:2623-2625.
16. Kornman KS, Newman MG, Moore DJ, Singer RE. The influence of supragingival plaque control on clinical and microbial outcomes following the use of antibiotics for the treatment of periodontitis. J Periodontol 1994;65: 848-854.
17. Michalowicz BS. Genetic and heritable risk factors in periodontal disease. J Periodontol 1994;65:479-488.
18. Hart TC. Genetic considerations of risk in human periodontal disease. Curr Opin Periodontol 1994;3-11.
19. Salvi GE, Yalda B, Collins JG, et al. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. J Periodontol 1997;68:127-135.
20. Tsai CC, Ho YP, Chen CC. Levels of interleukin-1 beta and interleukin-8 in gingival crevicular fluid in adult periodontitis. J Periodontol 1995;66:852-859.
21. Assuma R, Oates T, Cochran D, Amar S, Graves D. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol 1998;160:403-409.